Drug companies look to AI to end 'hit and miss' research | Pharmaceuticals industry | T... - 0 views
-
dr tech on 20 Feb 21"Functional genomics - a new area of science that looks at why small changes in a person's genetic make-up can increase the risk of diseases - deals with huge datasets. Each person has about 30,000 genes, which can be combined with others, as Hal Barron, GSK's chief scientific officer, explains. "You start to realise you're dealing with trillions and trillions of data points, even per experiment, and no human can interpret that, it's just too complicated.""